Stay updated with breaking news from Pascal Deschatelets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Should You Buy or Sell Apellis Pharmaceuticals Stock? Get The Latest APLS Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
EFG Asset Management North America Corp. lessened its position in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating) by 7.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 25,377 shares of the company’s stock after selling 1,955 shares during the quarter. EFG […]
HC Wainwright restated their buy rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Get Rating) in a report released on Thursday, Benzinga reports. They currently have a $87.00 price objective on the stock. Several other brokerages also recently commented on APLS. Robert W. Baird boosted their target price on Apellis Pharmaceuticals from $90.00 to $105.00 […]
Apellis Pharmaceuticals (NASDAQ:APLS – Get Rating) had its price target hoisted by The Goldman Sachs Group from $124.00 to $141.00 in a report released on Friday, Benzinga reports. The brokerage currently has a buy rating on the stock. Several other brokerages also recently commented on APLS. Wedbush lifted their target price on Apellis Pharmaceuticals from […]
Should You Buy or Sell Apellis Pharmaceuticals Stock? Get The Latest APLS Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.